Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 12
Submit an article Journal homepage
522
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

Djordje Atanackovic Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, GermanyCorrespondence[email protected]
,
Henrike Reinhard Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Sabrina Meyer Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Stefanie Spöck Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Tobias Grob Institute for Pathology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Tim Luetkens Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Sara Yousef Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Yanran Cao Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
York Hildebrandt Department of Stem Cell Transplantation; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Julia Templin Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Katrin Bartels Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Nesrine Lajmi Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Heribert Stoiber Division of Virology; Medical University IBK; Innsbruck, Austria
,
Nicolaus Kröger Department of Stem Cell Transplantation; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
,
Judith Atz Fresenius Biotech GmbH; Munich, Germany
,
Diane Seimetz Fresenius Biotech GmbH; Munich, Germany
,
Jakob R Izbicki Department of General, Visceral, and Thoracic Surgery; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
&
Carsten Bokemeyer Department of Internal Medicine II; Oncology/Hematology/Bone Marrow Transplantation with the section Pneumology; University Medical Center Hamburg-Eppendorf; Hamburg, Germany
 show all
Pages 2533-2542 | Received 18 Jan 2013, Accepted 06 Aug 2013, Published online: 16 Aug 2013

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gui-Xia Wei, Yang Du, Yu-Wen Zhou, Lin-Juan Li & Meng Qiu. (2022) Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives. Expert Review of Gastroenterology & Hepatology 16:9, pages 851-861.
Read now
Karin Taylor, Christopher B Howard, Martina L Jones, Ilya Sedliarou, Jennifer MacDiarmid, Himanshu Brahmbhatt, Trent P Munro & Stephen M Mahler. (2015) Nanocell targeting using engineered bispecific antibodies. mAbs 7:1, pages 53-65.
Read now

Articles from other publishers (18)

Hui Cao, Jun Diao, Huosheng Liu, Suxian Liu, Jun Liu, Jianye Yuan & Jiang Lin. (2023) The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 29:5, pages 818-829.
Crossref
Raquel Gomez-Bris, Angela Saez, Beatriz Herrero-Fernandez, Cristina Rius, Hector Sanchez-Martinez & Jose M. Gonzalez-Granado. (2023) CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease. International Journal of Molecular Sciences 24:3, pages 2696.
Crossref
Daisuke Kamakura, Ryutaro Asano & Masahiro Yasunaga. (2021) T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity. Pharmaceuticals 14:11, pages 1172.
Crossref
G. Fucà, A. Spagnoletti, M. Ambrosini, F. de Braud & M. Di Nicola. (2021) Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy. ESMO Open 6:1, pages 100046.
Crossref
A. Charlotte M. T. de Wolf, Carla A. Herberts & Marcel H. N. Hoefnagel. (2020) Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised. Frontiers in Medicine 7.
Crossref
Jennifer L Leiting & Travis E Grotz. (2018) Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World Journal of Gastrointestinal Oncology 10:10, pages 282-289.
Crossref
Abbas Alibakhshi, Fatemeh Abarghooi Kahaki, Shahrzad Ahangarzadeh, Hajar Yaghoobi, Fatemeh Yarian, Roghaye Arezumand, Javad Ranjbari, Ahad Mokhtarzadeh & Miguel de la Guardia. (2017) Targeted cancer therapy through antibody fragments-decorated nanomedicines. Journal of Controlled Release 268, pages 323-334.
Crossref
Jeffrey Reha & Steven C. Katz. (2017) Regional immunotherapy for liver and peritoneal metastases. Journal of Surgical Oncology 116:1, pages 46-54.
Crossref
A Trivedi, S Stienen, M Zhu, H Li, T Yuraszeck, J Gibbs, T Heath, R Loberg & S Kasichayanula. (2017) Clinical Pharmacology and Translational Aspects of Bispecific Antibodies. Clinical and Translational Science 10:3, pages 147-162.
Crossref
Nina Deppisch, Peter Ruf, Nina Eißler, Horst Lindhofer & Ralph Mocikat. (2016) Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition. Oncotarget 8:3, pages 4520-4529.
Crossref
N. Haense, A. Atmaca, C. Pauligk, K. Steinmetz, F. Marmé, G. M. Haag, M. Rieger, O. G. Ottmann, P. Ruf, H. Lindhofer & S.-E. Al-Batran. (2016) A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors. BMC Cancer 16:1.
Crossref
Masha Zeltsman, Marissa Mayor, David R. Jones & Prasad S. Adusumilli. (2016) Surgical immune interventions for solid malignancies. The American Journal of Surgery 212:4, pages 682-690.e5.
Crossref
Marco Fossati, Alexia Buzzonetti, Giovanni Monego, Valentina Catzola, Giovanni Scambia, Andrea Fattorossi & Alessandra Battaglia. (2015) Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3). Gynecologic Oncology 138:2, pages 343-351.
Crossref
Friedhelm R. Schuster, Michael Stanglmaier, Wilhelm Woessmann, Beate Winkler, Meinolf Siepermann, Roland Meisel, Paul G. Schlegel, Jürgen Hess, Horst Lindhofer, Arndt Borkhardt & Raymund Buhmann. (2015) Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies. British Journal of Haematology 169:1, pages 90-102.
Crossref
Alexander B. Dillon, Kevin Lin, Andrew Kwong & Susana Ortiz. (2015) Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies. AIMS Public Health 2:1, pages 86-114.
Crossref
Dmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, Judith Niesen, Katharina Arens, Nina Berges, Lea Hein, Stefano Di Fiore, Anh-Tuan Pham, Michael Huhn, Wijnand Helfrich, Rainer Fischer, Theo Thepen & Stefan Barth. (2014) EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein. Molecular Cancer Therapeutics 13:9, pages 2194-2202.
Crossref
Ron D. Jachimowicz, Sven Borchmann & Achim Rothe. (2014) Multi-Specific Antibodies for Cancer Immunotherapy. BioDrugs 28:4, pages 331-343.
Crossref
Cord Naujokat. (2014) Monoclonal antibodies against human cancer stem cells. Immunotherapy 6:3, pages 290-308.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.